Search results for "Carrier state"

showing 10 items of 38 documents

Cryptic Leishmania infantum infection in Italian HIV infected patients.

2008

Abstract Background Visceral leishmaniasis (VL) is a protozoan diseases caused in Europe by Leishmania (L.) infantum. Asymptomatic Leishmania infection is more frequent than clinically apparent disease. Among HIV infected patients the risk of clinical VL is increased due to immunosuppression, which can reactivate a latent infection. The aims of our study were to assess the prevalence of asymptomatic L. infantum infection in HIV infected patients and to study a possible correlation between Leishmania parasitemia and HIV infection markers. Methods One hundred and forty-five HIV infected patients were screened for the presence of anti-Leishmania antibodies and L. infantum DNA in peripheral blo…

AdultMaleSettore MED/17 - Malattie InfettiveAntibodies ProtozoanHIV InfectionsParasitemiaBiologyParasitemiaAsymptomaticlcsh:Infectious and parasitic diseasesYoung Adultparasitic diseasesmedicinePrevalenceHumanslcsh:RC109-216Leishmania infantumAgedHIVLeishmaniasisDNA ProtozoanMiddle Agedmedicine.diseasebiology.organism_classificationVirologyCryptic infectionCryptic infectionVisceral leishmaniasisInfectious DiseasesPCRItalyImmunoglobulin GImmunologyCarrier StateLeishmaniasis VisceralRegression AnalysisFemalemedicine.symptomLeishmania infantumViral loadAsymptomatic carrierResearch Article
researchProduct

Alteration of Smell and Taste in Asymptomatic and Symptomatic COVID-19 Patients in Sicily, Italy

2020

Objectives: Alteration of smell and taste has been reported in patients with coronavirus disease 2019 (COVID-19). The incidence and clinical-symptomatic manifestation of COVID-19 is different between northern and southern Italy. This study aims to evaluate the onset of alteration of smell and taste in asymptomatic and symptomatic patients in Sicily (extreme south of Italy). Methods: This prospective cross-sectional study was performed on asymptomatic and symptomatic COVID-19 patients tested for severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) from May 1 to May 15, 2020. A questionnaire was used for evaluating the prevalence of smell and taste disorders in COVID-19 patients befor…

AdultMaleTaste2019-20 coronavirus outbreakFeverCoronavirus disease 2019 (COVID-19)RhinorrheaAnosmiaAsymptomaticTaste Disorders03 medical and health sciences0302 clinical medicinemedicineHumansIn patientProspective Studies030212 general & internal medicine030223 otorhinolaryngologySicilyFatigueAgedAged 80 and overSmell DisordersSARS-CoV-2business.industryIncidenceIncidence (epidemiology)COVID-19PharyngitisMiddle AgedHospitalizationCross-Sectional StudiesDyspneaCoughItalyOtorhinolaryngologyTaste disorderCarrier StateImmunologyFemalemedicine.symptombusinessEar, Nose & Throat Journal
researchProduct

Candidal carriage in the oral cavity of human immunodeficiency virus–infected subjects

2002

Abstract Objectives. We sought to assess asymptomatic oral carriage of Candida species and relative density in human immunodeficiency virus-infected (HIV+) subjects, as well as to determine whether yeast carriage is associated with CD4+cell count, HIV-1 RNA quantity, gender, route of HIV transmission, antiretroviral therapy, or smoking. Study Design. A cross-sectional analysis of oral rinses from HIV+ and healthy subjects was undertaken. Oral candidal carriage and relative species were investigated in 42 HIV+ and 41 healthy individuals, all of whom were seen at the Palermo University Department of Oral Sciences, Italy. Data were managed and analyzed by means of the computer software package…

AdultMalemedicine.medical_specialtyColony Count MicrobialAsymptomaticStatistics NonparametricAcquired immunodeficiency syndrome (AIDS)Candidiasis OralInternal medicineHumansMedicineMycological Typing TechniquesSidaCandida albicansGeneral DentistryMycosisCandidaMouthChi-Square DistributionAIDS-Related Opportunistic Infectionsbiologybusiness.industryMiddle AgedViral Loadbiology.organism_classificationmedicine.diseaseCD4 Lymphocyte CountCross-Sectional StudiesCarriageOtorhinolaryngologyOral microbiologyCarrier StateImmunologyHIV-1FemaleSurgeryOral Surgerymedicine.symptombusinessViral loadOral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology
researchProduct

Hepatitis C virus RNA profiles in chronically infected individuals: do they relate to disease activity?

1999

Fluctuations of hepatitis C virus (HCV)-RNA serum levels were monitored in a multicenter study in 76 chronic HCV carriers who had been followed longitudinally without receiving antiviral therapy to assess their relation with the course of liver disease activity. Forty-four patients had normal transaminases over more than 2 years, while 32 additional patients had fluctuating levels. Viral load was measured in serial serum samples prospectively collected for 10 to 12 months in 54 patients and in sera stored yearly up to 8 years in an additional 22 patients. In patients tested monthly, a lesser extent of fluctuations was detected in cases with constantly normal transaminases as compared with t…

AdultMalemedicine.medical_specialtyGenotypeHepatitis C virusHepacivirusViremiaHepacivirusmedicine.disease_causeGastroenterologyAsymptomaticLiver diseaseFlaviviridaeInternal medicinemedicineHumansLongitudinal StudiesViremiaAgedHepatologybiologybusiness.industryAlanine TransaminaseHepatitis C ChronicMiddle Agedmedicine.diseasebiology.organism_classificationLiverImmunologyCarrier StateRNA ViralFemaleViral diseasemedicine.symptombusinessViral loadHepatology (Baltimore, Md.)
researchProduct

An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers

2009

Summary.  Liver biopsy is frequently required in HBeAg-negative disease to determine the stage of fibrosis. It can be difficult to distinguish cohorts with undetectable HBeAg who may have varying degrees of fibrosis due to different stages of disease. We have assessed the utility of transient elastography (TE) to evaluate differences in HBeAg-negative patients. A total of 220 HBsAg-positive individuals were studied: 125 (group 1) had an inactive HBsAg carrier state and 95 (group 2) were HBeAg-negative, anti-HBe-positive patients with persistently or intermittent elevation of alanine aminotransferase (ALT) and/or HBV DNA >105 copies/mL. Mean stiffness was 4.83 ± 1.2 kPa in group 1 vs 8.53 ± …

AdultMalemedicine.medical_specialtyPathologyHepatitis B virusBiopsymedicine.disease_causeGastroenterologyDiagnosis DifferentialYoung Adultfibroscan hepatitis B hepatitis B virus transient elastography type B hepatitis HBeAgFibrosisVirologyInternal medicineBiopsymedicineHumansHepatitis B e AntigensHepatitis B AntibodiesAgedHepatitis B virusHepatitis B Surface AntigensHepatologymedicine.diagnostic_testbusiness.industryvirus diseasesAlanine TransaminaseHepatitis BMiddle Agedmedicine.diseaseHepatitis Bdigestive system diseasesInfectious DiseasesCross-Sectional StudiesFibroscan; hepatitis B virus; transient elastography; type B hepatitis HBeAgHBeAgLiverLiver biopsyCarrier StateElasticity Imaging TechniquesFemalebusinessTransient elastographyViral hepatitis
researchProduct

MRS SHOWS ABNORMALITIES BEFORE SYMPTOMS IN FAMILIAL ALZHEIMER DISEASE

2006

Background: Pathologic change in Alzheimer disease (AD) begins some years before symptoms. MRS has the potential to detect metabolic abnormalities reflecting this early pathologic change. Presenilin 1 (PS1) and amyloid precursor protein (APP) mutation carriers have a nearly 100% risk of developing AD and may be studied prior to symptom onset. Methods: Short echo time proton MR spectra were acquired from a midline posterior cingulate voxel in presymptomatic carriers of PS1 or APP mutations (“presymptomatic mutation carriers” [PMCs]; n = 7) and age- and sex-matched control subjects (n = 6). Ratios of N-acetyl aspartate (NAA), myo-inositol (MI), and choline-containing compounds (Cho) to creati…

AdultMalemedicine.medical_specialtyPathologyMagnetic Resonance SpectroscopyAlzheimer disease brain metabolism nuclear magnetic resonance spectroscopyAdolescentNeuropsychological TestsCreatineGastroenterologyPresenilinCentral nervous system diseasechemistry.chemical_compoundDegenerative diseaseAlzheimer DiseaseReference ValuesInternal medicinemental disordersmedicineHumansFamilySymptom onsetAge of OnsetChildSettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaBrainInfantMiddle Agedmedicine.diseaseControl subjectsnervous system diseasesnervous systemchemistryChild PreschoolCarrier StateFemaleNeurology (clinical)Alzheimer's diseaseGeometric meanPsychology
researchProduct

Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years

2004

Background & aims: Increased morbidity and mortality from liver disease have been reported in chronic hepatitis B surface antigen (HBsAg) carriers, but data on survival are equivocal. To assess the impact of hepatitis B virus (HBV) infection on survival and liver-related complications, we re-evaluated, after a mean follow-up of 30 years, a cohort of 296 blood donors excluded from donation 30 years ago when HBsAg screening became mandatory. Methods: Clinical and ultrasound examination and biochemical and virologic tests were performed. The cause of death was recorded and survival was compared with a control population of 157 HBV-negative blood donors selected at baseline. Results: Thirty-two…

AdultMalevirus DNAmedicine.medical_specialtyHBsAgHepatitis B virusCirrhosisBlood Donorsmedicine.disease_causeGastroenterologyserum HBVCohort StudiesLiver diseaseHepatitis B ChronicInternal medicinemedicineHumansProspective StudiesSurvival analysisCause of deathAgedHepatitis B virusHepatitis B Surface AntigensHepatologybusiness.industryalcoholGastroenterologyHepatitis BMiddle Agedmedicine.diseaseSurvival Analysisdigestive system diseaseshepatitis B surface antigenItalygamma glutamyltransferaseHepatocellular carcinomaImmunologyCarrier StateFemalebusinessFollow-Up Studies
researchProduct

Hepatitis B vaccination of relatives of hepatitis B virus DNA positive carriers: an experience with plasma-derived vaccine.

1989

We assessed in a western population the efficacy of a plasma-derived hepatitis B vaccine in relatives of highly infectious hepatitis B virus (HBV) carriers. A consecutive group of 103 HbsAg, anti-HBs and anti-HBc negative household relatives of 45 HBV-DNA positive chronic carriers received a 5 micrograms dose of plasma-derived vaccine at 0, 1, 2 and 12 months. Protective levels of immunity developed in 101 subjects (97.8%) 3 months after boosting. Low responders to the vaccine were mostly found among parents and spouses of carriers, whilst offspring and siblings were usually high responders. The main discriminant in predicting a good response was age below 12 years. Hyporesponsiveness did n…

AdultViral Hepatitis VaccinesHBsAgHepatitis B vaccineEpidemiologyPopulationmedicine.disease_causeImmune systemImmunityRisk FactorsMedicineHumansHepatitis B VaccinesHepatitis B AntibodieseducationHepatitis B viruseducation.field_of_studyHepatitis B Surface Antigensbusiness.industryInfant Newbornvirus diseasesInfantHepatitis Bmedicine.diseaseHepatitis BVirologyHepatitis B Core Antigensdigestive system diseasesVaccinationImmunologyCarrier StatebusinessDNA ProbesEuropean journal of epidemiology
researchProduct

Occult Hepatitis B and Infliximab-induced HBV Reactivation

2007

Crohn diseasebusiness.industryCarrier stateGastroenterologyHbv reactivationVirus ActivationHepatitis Bmedicine.diseaseVirologyOccultInfliximabAntibodies monoclonalmedicineImmunology and Allergybusinessmedicine.drugInflammatory Bowel Diseases
researchProduct

Virulence and Molecular Typing of Vibrio harveyi Strains Isolated from Cultured Dentex, Gilthead Sea Bream and European Sea Bass

2003

Vibrio harveyi was isolated from internal organs or ulcers of diseased and apparently healthy gilthead sea bream (Sparus aurata) and European sea bass (Dicentrarchus labrax) cultured in several fish farms located on the Spanish Mediterranean coast. The prevalence of the bacterium was significantly higher in European sea bass than in gilthead sea bream, and was closely related to the season in both fish species, occurring almost exclusively on warm months (June to November). After phenotypic characterization, a selection of forty five isolates from gilthead sea bream, sea bass, and several isolates previously obtained from common dentex (Dentex dentex) of the same area, were molecularly type…

DNA BacterialFish farmingFisheriesVirulenceZoologyMediterranean aquacultureRibotypingApplied Microbiology and BiotechnologyMicrobiologyFish DiseasesRibotypingRAPDSparus aurataAnimalsDicentrarchus labraxSea bassFish pathogensEcology Evolution Behavior and SystematicsVibrioVirulencebiologyVibrio harveyiLD50Dentex dentexbiology.organism_classificationVibrio harveyiSea BreamBacterial Typing TechniquesPerciformesRandom Amplified Polymorphic DNA TechniqueRAPDFisheryPhenotypeVibrio InfectionsCarrier StateBassDicentrarchussense organsDentex dentexSystematic and Applied Microbiology
researchProduct